FeaturesSignalPricingFounders
Log inGet started free
VV

Versant Ventures

Venture CapitalActive

Versant Ventures caters to the healthcare sector with early and later stage venture, private equity, and debt financing investments.

Menlo Park, United StatesFounded 2005versantventures.com
311
Investments
7
Exits
$4.0B
AUM
2.3%
Exit Rate

Get contact info, warm intros & fit scores

Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Versant Ventures.

Get started free

Investment Thesis & Strategy

Versant Ventures invests in early and later-stage healthcare companies, providing venture capital, private equity, and debt financing. They focus on the healthcare sector, seeking to support companies through various stages of growth.

Investment Activity

Deals per year over the last 12 years

1
2008
0
2009
0
2010
0
2011
3
2012
1
2013
0
2014
1
2015
2
2016
1
2017
1
2018
2
2019

Portfolio Companies

Selected investments from their portfolio of 311 companies

L
Lyell Immunopharma
Biotech · Series B, 2019
Active
V
Verve Therapeutics
Biotech · Series A, 2019
Active
B
Beam Therapeutics
Biotech · Series A, 2018
Active
O
Obsidian Therapeutics
Biotech · Series A, 2017
Active
M
Magenta Therapeutics
Biotech · Series A, 2016
Active
I
Inari Medical
Healthcare · Series B, 2016
Active
R
Revolution Medicines
Biotech · Series A, 2015
Active
A
Audentes Therapeutics
Biotech · Series A, 2013
Active
M
MyoKardia
Biotech · Series A, 2012
Active
C
Crinetics Pharmaceuticals
Biotech · Series A, 2012
Active
P
Protagonist Therapeutics
Biotech · Series A, 2012
Active
C
Celladon
Biotech · Series A, 2008
Active

Notable Exits

CompanyTypeYearValue / Acquirer
Obsidian TherapeuticsIPO2024
Lyndra TherapeuticsAcquisition2024
Verve TherapeuticsIPO2021
MyoKardiaAcquisition2020$13.1B
Revolution MedicinesIPO2020
SequentaAcquisition2015$302M
Portola PharmaceuticalsIPO2013

Frequently Asked Questions

Versant Ventures focuses on Series A, Series B, Series C+ stage investments.

Related Investors